Latest Ratios: P/E Ratio 17.7x · EV/EBITDA 6.0x · ROE 2.3%. (2002–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.7B | $3.7B | $3.1B | $3.2B | $2.7B | $2.1B | $1.9B | $2.2B | $2.3B | $1.6B | $1.9B |
| Enterprise Value | $3.2B | $3.2B | $2.5B | $2.5B | $2.5B | $2.4B | $2.8B | $2.9B | $4.5B | $3.3B | $3.7B |
| P/E Ratio → | 17.67 | 16.72 | 10.28 | 41.75 | 4.45 | 2.30 | 2.54 | 4.31 | 19.42 | 1.91 | — |
| P/S Ratio | 0.58 | 0.59 | 0.43 | 0.43 | 0.37 | 0.27 | 0.24 | 0.29 | 0.30 | 0.21 | 0.23 |
| P/B Ratio | 0.40 | 0.38 | 0.33 | 0.38 | 0.32 | 0.13 | 0.12 | 0.15 | 0.16 | 0.10 | 0.13 |
| P/FCF | 11.24 | 11.43 | 34.90 | 5.31 | 2.58 | 4.77 | 0.87 | 1.08 | 1.43 | 0.61 | 1.03 |
| P/OCF | 11.24 | 11.43 | 34.90 | 5.31 | 2.58 | 4.77 | 0.99 | 1.08 | 1.43 | 0.61 | 1.03 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.51 | 0.36 | 0.34 | 0.34 | 0.32 | 0.34 | 0.37 | 0.57 | 0.43 | 0.44 |
| EV / EBITDA | 5.99 | 6.11 | 3.58 | 6.04 | 1.71 | 1.90 | 2.47 | 3.84 | 11.43 | 8.29 | 5.60 |
| EV / EBIT | 7.28 | 5.98 | 3.58 | 6.04 | 1.71 | 1.90 | 2.47 | 3.84 | 11.43 | 8.29 | 5.60 |
| EV / FCF | — | 9.83 | 28.88 | 4.26 | 2.40 | 5.52 | 1.25 | 1.39 | 2.75 | 1.28 | 1.99 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.3% | 24.3% | 7.8% | 4.1% | 18.6% | 13.8% | 12.8% | 9.8% | 4.8% | 5.2% | 7.8% |
| Operating Margin | 6.8% | 6.8% | 8.3% | 4.1% | 18.5% | 14.6% | 11.3% | 6.8% | 1.7% | 1.7% | 3.8% |
| Net Profit Margin | 3.5% | 3.5% | 4.2% | 1.0% | 12.4% | 11.2% | 2.2% | 4.5% | 1.5% | 10.9% | -3.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.3% | 2.3% | 3.4% | 0.9% | 7.4% | 5.3% | 1.2% | 2.4% | 0.8% | 5.5% | -1.9% |
| ROA | 0.3% | 0.3% | 0.3% | 0.1% | 1.0% | 0.8% | 0.2% | 0.3% | 0.1% | 0.8% | -0.3% |
| ROIC | 3.6% | 3.6% | 5.4% | 2.9% | 8.3% | 5.0% | 4.4% | 2.5% | 0.6% | 0.6% | 1.5% |
| ROCE | 0.6% | 0.6% | 0.7% | 0.3% | 1.4% | 1.1% | 0.9% | 0.5% | 0.8% | 0.7% | 1.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.16 | 0.19 | 0.19 | 0.12 | 0.22 | 0.27 | 0.31 | 0.30 | 0.32 |
| Debt / EBITDA | 2.88 | 2.88 | 2.14 | 3.76 | 1.10 | 1.49 | 3.03 | 5.30 | 11.03 | 11.64 | 6.95 |
| Net Debt / Equity | — | -0.05 | -0.06 | -0.08 | -0.02 | 0.02 | 0.05 | 0.04 | 0.15 | 0.11 | 0.12 |
| Net Debt / EBITDA | -0.99 | -0.99 | -0.75 | -1.50 | -0.13 | 0.26 | 0.75 | 0.86 | 5.49 | 4.32 | 2.71 |
| Debt / FCF | — | -1.60 | -6.02 | -1.06 | -0.18 | 0.75 | 0.38 | 0.31 | 1.32 | 0.67 | 0.96 |
| Interest Coverage | 5.12 | 5.12 | 6.17 | 3.57 | 13.88 | 7.95 | 5.76 | 3.26 | 1.54 | 1.48 | 1.95 |
Net cash position: cash ($2.0B) exceeds total debt ($1.5B)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.91 | 1.91 | — | — | — | — | — | — | 0.03 | 0.03 | 0.03 |
| Quick Ratio | 1.91 | 1.91 | — | — | — | — | — | — | 0.03 | 0.03 | 0.03 |
| Cash Ratio | 0.58 | 0.58 | — | — | — | — | — | — | 0.74 | 0.76 | 0.73 |
| Asset Turnover | — | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 0.7% | — | — | — | — | 3.9% | 4.2% | 6.9% | 7.3% |
| Payout Ratio | — | — | 7.0% | — | — | — | — | 25.4% | 81.5% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.7% | 6.0% | 9.7% | 2.4% | 22.5% | 43.5% | 39.4% | 23.2% | 5.2% | 52.4% | — |
| FCF Yield | 8.9% | 8.7% | 2.9% | 18.8% | 38.8% | 21.0% | 115.2% | 92.7% | 70.0% | 163.8% | 97.5% |
| Buyback Yield | 8.7% | 8.5% | 6.2% | 9.3% | 2.4% | 0.0% | 0.0% | 1.0% | 0.0% | 2.1% | 0.0% |
| Total Shareholder Yield | 8.7% | 8.5% | 6.8% | 9.3% | 2.4% | 0.0% | 0.0% | 4.9% | 4.2% | 9.0% | 7.3% |
| Shares Outstanding | — | $414M | $439M | $475M | $511M | $515M | $512M | $510M | $500M | $501M | $498M |
Legacy LTC reserve volatility
Trading at a P/B of 0.40, Genworth’s valuation remains significantly depressed compared to mortgage insurance peers like MGIC Investment Corp, which command multiples above 1.2x, suggesting that the market heavily discounts the company due to the persistent overhang of its legacy long-term care insurance liabilities.
The valuation gap appears to be a structural reflection of the market's skepticism regarding the U.S. Life segment's ability to achieve sustainable profitability. Investors should monitor whether the ongoing de-risking of the parent company and the potential for improved capital returns can eventually narrow this discount relative to pure-play mortgage insurance competitors.
As evidenced by the fluctuation in the combined ratio from a peak of 111.6% in 2023Q4 to 98.8% in 2025Q4, Genworth’s underwriting profitability remains highly sensitive to actuarial adjustments, which complicates the assessment of long-term sustainability in its core insurance operations.
The erratic nature of the loss ratio, which reached 112.2% in 2023Q4, underscores the inherent difficulty in managing long-tail morbidity risks. While recent quarters show a trend toward stabilization, the reliance on periodic reserve re-measurements suggests that underwriting margins may remain prone to sudden, material shifts that could impact overall financial performance.
Based on reported quarterly figures, Genworth’s ROE has struggled to maintain positive momentum, hovering near 0.8% in 2026Q1, which indicates that the contribution of underwriting profits is frequently offset by the capital-intensive requirements of the legacy long-term care block and associated reserve adjustments.
The company's inability to generate consistent, double-digit ROE levels highlights the drag created by its legacy portfolio compared to more efficient peers. Future profitability improvements appear contingent on the successful execution of premium rate increases and the potential for investment income to better offset the long-term liability tail.
Investors frequently misapply the P/E ratio to Genworth, which, at 17.52x, fails to account for the significant volatility introduced by LDTI accounting standards and the non-cash reserve adjustments that frequently distort reported net income, making it a poor proxy for the company's underlying economic value.
Because reported earnings are heavily influenced by actuarial assumptions rather than cash-generative underwriting, the P/E ratio obscures the true health of the business. Analysts should instead prioritize adjusted book value and segment-specific cash flow metrics to better evaluate the company's progress in managing its legacy insurance risks.
Includes 30+ ratios · 24 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GNW stock.
Genworth Financial, Inc.'s current P/E ratio is 17.7x. The historical average is 22.2x. This places it at the 76th percentile of its historical range.
Genworth Financial, Inc.'s current EV/EBITDA is 6.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.4x.
Genworth Financial, Inc.'s return on equity (ROE) is 2.3%. The historical average is 2.6%.
Based on historical data, Genworth Financial, Inc. is trading at a P/E of 17.7x. This is at the 76th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Genworth Financial, Inc. has 24.3% gross margin and 6.8% operating margin.
Genworth Financial, Inc.'s Debt/EBITDA ratio is 2.9x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.